In last trading session, Cg Oncology Inc (NASDAQ:CGON) saw 1.3 million shares changing hands with its beta currently measuring 1.27. Company’s recent per share price level of $22.24 trading at $0.19 or 0.86% at ring of the bell on the day assigns it a market valuation of $1.70B. That closing price of CGON’s stock is at a discount of -111.29% from its 52-week high price of $46.99 and is indicating a premium of 1.39% from its 52-week low price of $21.93. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.95 million shares which gives us an average trading volume of 656.30K if we extend that period to 3-months.
For Cg Oncology Inc (CGON), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Cg Oncology Inc (NASDAQ:CGON) trade information
Upright in the green during last session for gaining 0.86%, in the last five days CGON remained trading in the red while hitting it’s week-highest on Thursday, 03/27/25 when the stock touched $22.24 price level, adding 18.89% to its value on the day. Cg Oncology Inc’s shares saw a change of -22.45% in year-to-date performance and have moved -16.20% in past 5-day. Cg Oncology Inc (NASDAQ:CGON) showed a performance of -10.32% in past 30-days. Number of shares sold short was 7.23 million shares which calculate 11.7 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 57.5 to the stock, which implies a rise of 61.32% to its current value. Analysts have been projecting 55 as a low price target for the stock while placing it at a high target of 60. It follows that stock’s current price would drop -147.3% in reaching the projected high whereas dropping to the targeted low would mean a loss of -147.3% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around -28.22% while estimates for its earnings growth in next 5 years are of 38.86%.
Cg Oncology Inc (NASDAQ:CGON)’s Major holders
Insiders are in possession of 6.16% of company’s total shares while institution are holding 98.31 percent of that, with stock having share float percentage of 104.77%. Investors also watch the number of corporate investors in a company very closely, which is 98.31% institutions for Cg Oncology Inc that are currently holding shares of the company. DECHENG CAPITAL LLC is the top institutional holder at CGON for having 5.46 million shares of worth $172.33 million. And as of 2024-06-30, it was holding 8.1903 of the company’s outstanding shares.
The second largest institutional holder is TCG CROSSOVER MANAGEMENT, LLC, which was holding about 3.67 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.5067 of outstanding shares, having a total worth of $115.87 million.
